-
Mashup Score: 0Investigating Novel Immunotherapy Combinations for Advanced Gastric and Esophageal Cancers | Docwire News - 5 day(s) ago
Dr. Cytryn summarizes a trial in progress investigating a novel immunotherapy combination for gastroesophageal adenocarcinoma
Source: www.docwirenews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Evaluating Cemiplimab in la/mPC: New Findings From the Phase II EPIC-A Trial | GU Oncology Now - 5 day(s) ago
At ASCO GU 2025, researchers presented efficacy and safety findings from the EPIC-A trial of cemiplimab with SOC chemotherapy.
Source: www.guoncologynow.comCategories: General Medicine News, UrologyTweet-
👉 At @ASCO #GU25, researchers presented efficacy and safety findings from the EPIC-A trial of #cemiplimab with SOC chemotherapy for patients with locally advanced or metastatic penile cancer. 📋 Learn more about the effects of this combination: https://t.co/CK1JLxDeCC
-
-
Mashup Score: 0EAU Guidelines on Paediatric Urology - Uroweb - 5 day(s) ago
The European Association of Urology (EAU) Paediatric Urology Guidelines Panel has prepared these Guidelines with the aim of increasing the quality of care for children with urological conditions.
Source: uroweb.orgCategories: General Medicine News, UrologyTweet-
Big News in Paediatric Urology! New clinical guidelines for spinal dysraphism in children & adolescents are here, focusing on: ✅ Early detection of urological complications ✅ Protecting kidney & bladder health ✅ Long-term surveillance 🩺 Read more: https://t.co/iGhc5aCOe3 https://t.co/xmM3D5Bc5L
-
-
Mashup Score: 0
With a plethora of exciting activities, including Showcase presentations, reverse pitches, and mentorship opportunities, attendees have the opportunity to expand their knowledge and connect with industry experts like never before. Additionally, you’ll have access to exclusive insights from top business executives and the chance to connect with influential investors who can help take your ideas to the next level. Program areas include: Showcase: Through a rigorous and highly competitive selection process,
Source: www.auanexus.orgCategories: General Medicine News, UrologyTweet-
Have you registered for the 2025 Innovation Nexus Conference? Don't miss the most anticipated event of the year for urologic entrepreneurs, innovators, and investors! Learn more here ➡️ https://t.co/DqgzDUEuqn #AUAInnovationNexus #Urology #AUA25 https://t.co/lwPm7VdO3J
-
-
Mashup Score: 0
Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
The proportion of oncologists who were satisfied with their work-life integration decreased from 35% in 2013 to 24% in 2023. https://t.co/8AUrfGwuyp
-
-
Mashup Score: 0HHS Proposes HIPAA Privacy Rule Changes - 6 day(s) ago
Proposed changes to HIPAA regulations are meant to strengthen cybersecurity protections for electronic protected health information.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
A proposed rule would update the HIPAA Security Rule for the first time since 2013. Health plans, healthcare clearinghouses, and insurance companies would be required to strengthen cybersecurity protections for electronic protected health information. https://t.co/Ery4yawX4L
-
-
Mashup Score: 0Expert discusses emerging technologies, AI and BPH treatment - 6 day(s) ago
“What we’re really trying to see now is this integration of imaging and using it with respect to AI and planning,” says Dean S. Elterman, MD, MSc, FRCSC.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Dean Elterman, MD, MSc, FRCSC, (@DrDeanElterman) gives his perspective on the role of emerging technologies like robotic surgery and AI in the future of minimally invasive BPH treatment. #urology https://t.co/ZosIdRAF4q
-
-
Mashup Score: 0
“Taken altogether, the study remains positive for PFS, but not for overall survival,” says Laurence Albiges, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Laurence Albiges, MD, PhD, (@AlbigesL) shares final results from the phase 3 COSMIC-313 trial, which explored the efficacy of adding cabozantinib to nivolumab and ipilimumab in advanced renal cell carcinoma. #GU25 #RCC https://t.co/kdcaWeXl12
-
-
Mashup Score: 7EAU Guidelines on Prostate Cancer - TREATMENT - Uroweb - 6 day(s) ago
The Prostate Cancer (PCa) Guidelines Panel have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa.
Source: uroweb.orgCategories: General Medicine News, UrologyTweet-
In case of PSA progression or change in DRE or MRI findings, do not progress to active treatment without a repeat biopsy. #ProstateCancer #EAUguidelines https://t.co/0ax5QuNs6e
-
-
Mashup Score: 0
“Over 80% of patients…had at least 2 lines of therapy, so this is a heavily refractory population,” said Toni K. Choueiri, MD, FASCO.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
The investigational HIF-2α inhibitor casdatifan demonstrated promising clinical activity and was well tolerated in patients with previously treated clear cell renal cell carcinoma. #GU25 #RCC @DrChoueiri https://t.co/54vDHyj4hv
-
📺 Dr. @Sam_Cytryn of @MSKCancerCenter highlights his trial on a novel immunotherapy combo for refractory #gastroesophageal adenocarcinoma. 🔎 The study evaluates the use of agenT-797, #botensilimab, and #balstilimab, with #ramucirumab and #paclitaxel: https://t.co/kypHZCZE6J https://t.co/dg6ynIAPZ8